Temasek and Jack Ma fund lead $75m round for Chinese genomic company

Singapore state investor and Alibaba founder back big data for medical R&D

20170502_Tamasek

Singapore state investor Temasek is betting on the use of big data and smart technology in the medical sector.

TOMOMI KIKUCHI, Nikkei staff writer

SINGAPORE -- Singaporean state investor Temasek Holdings and private equity firm Yunfeng Capital, backed by Chinese e-commerce group Alibaba's founder Jack Ma, have led a $75 million funding round for WuXi NextCODE, a Chinese genomics data company.

According to an announcement from the genomics company on Tuesday, other investors in the fundraising include Amgen Ventures, the U.S. biotechnology group's venture capital fund, and 3W Partners, a private equity firm focused on greater China and cross-border deals.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.